Overview

Transcatheter aortic, mitral, and tricuspid therapies have emerged as important new therapy options for patients with valvular heart disease. Integrating non-invasive cardiac imaging, surgical experiences, and novel interventional approaches as part of a multidisciplinary heart team approach for diagnosis and planning of optimal treatment in complex patients with valvular heart disease.

Transcatheter Valve Therapies (TVT) is designed for interventional cardiologists, imaging specialists, clinical cardiologists, scientists, vascular medicine specialists, cardiac and vascular surgeons, nurse practitioners, cath lab technicians, and other healthcare professionals. TVT will provide a comprehensive review of the best clinical practices in the management of valvular heart disease, including in-depth coverage of less invasive transcatheter devices currently in use or under investigation.

TVT 2018 COURSE HIGHLIGHTS

  • 1. Live case demonstrations of transcatheter aortic and mitral-tricuspid valve interventions from multiple US and international sites
  • 2. Workshops on clinical controversies and physician training topics
  • 3. Challenging case presentations, late-breaking clinical trials, innovative technology sessions, and poster abstracts from attendees
  • 4. Bioskills sessions of cardiac anatomy with integrated echo and MSCT imaging
  • 5. Interactive and hands-on physician training workshops including trans-septal techniques, MitraClip, and new TAVR technologies
  • 6. A full day structural heart disease imaging workshop (echo, MSCT, and others)

CME And MOC Accreditation And Evaluation

The Cardiovascular Research Foundation designates this live activity for a maximum of 20.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Documentation of awarded credit is provided for registered attendees who complete the activity evaluation on the app or online. Certificates of attendance are available to all registered attendees.

Disclosure Statement

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.

Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage are not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.

Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty not complying with this policy are not permitted to participate in this activity.